Belite Bio, Inc
NASDAQ:BLTEBiotechnology
Healthcare
$151.02 +0.31%
+$0.46 today
- Market cap
- $6.08B
- Beta
- -1.24
- P/E (TTM)
- -65.9
- EPS (TTM)
- -$2.26
52W Low $56.10High $200.00
Volume 0.14M
Average 0.17M
Balance Sheet
Inspect the capital base behind the business.
Assets
$780.56M
FY 2025 · Annual
+413.1% YoYLiabilities
$10.07M
FY 2025 · Annual
+59.6% YoYEquity
$770.49M
FY 2025 · Annual
+428.4% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 17.34M | 42.09M | 88.16M | 31.68M | 352.93M |
| Short-term Investments | 0 | 0 | 0 | 113.47M | 139.49M |
| Net Receivables | 23K | 19K | 867K | 594K | 718K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 5K |
| Total Current Assets | 17.43M | 42.81M | 89.94M | 147.07M | 494.27M |
| Property, Plant & Equipment (Net) | 94K | 1.35M | 1.3M | 965K | 777K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 31K | 3.3M | 3.99M | 4.92M |
| Long-term Investments | 0 | 0 | 0 | 0 | 280.17M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 823K | 88K | 104K | 103K | 425K |
| Total Non-current Assets | 917K | 1.47M | 4.7M | 5.06M | 286.28M |
| Total Assets | 18.35M | 44.27M | 94.64M | 152.13M | 780.56M |
| Account Payables | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 24K | 456K | 876K | 992K | 2.21M |
| Total Current Liabilities | 1.64M | 2.1M | 3.63M | 6.05M | 9.88M |
| Long-term Debt | 31.81M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 31.81M | 668K | 578K | 261K | 188K |
| Total Liabilities | 33.44M | 2.77M | 4.21M | 6.31M | 10.07M |
| Common Stock | 1K | 3K | 3K | 3K | 4K |
| Retained Earnings | (27.22M) | (39.87M) | (71.5M) | (107.65M) | (185.26M) |
| Accumulated OCI | (196K) | (392K) | (374K) | (660K) | (536K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (15.09M) | 41.5M | 90.43M | 145.82M | 770.49M |
| Total Debt | 31.81M | 866K | 886K | 537K | 429K |
| Net Debt | 14.46M | (41.22M) | (87.27M) | (31.14M) | (352.5M) |
Balance Sheet
Assets, liabilities & equity
| Other Current | $501.6M |
| Total Current Assets | $501.6M |
| Other Non-current | $290.0M |
| Total Non-current Assets | $290.0M |
| Total Assets | $791.6M |
Analysis
Selected assets total $791.6M for Latest. The largest visible component is Other Current at $501.6M, about 63.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 30, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 30, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 30, 2026 | |
| 6-K | 6-K filing | Oct 19, 2026 |
How much cash does BLTE have?
Belite Bio, Inc (BLTE) reported $352.93M in cash and equivalents in fiscal 2025.
How much debt does BLTE carry?
Belite Bio, Inc (BLTE) reported $429,000.00 of total debt, with net debt of -$352.50M.
Continue the stock analysis
Jump to another research area for this company.